Mersana Therapeutics, Inc.
MRSN
$0.3659
$0.00982.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.88% | -22.75% | 52.61% | -25.70% | 1.22% |
| Total Depreciation and Amortization | -21.00% | -0.50% | -0.25% | -4.73% | -5.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.82% | -7.78% | -0.73% | -8.44% | -5.98% |
| Change in Net Operating Assets | 1.28% | -538.43% | 27.32% | 89.08% | -3.61% |
| Cash from Operations | -52.33% | -124.45% | 60.75% | 33.08% | -2.17% |
| Capital Expenditure | -- | -- | -- | 100.00% | 65.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.00% | 75.62% | 416.32% | 107.61% | -452.66% |
| Cash from Investing | -46.00% | 75.62% | 416.32% | 107.60% | -460.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -49.74% | -9,008.70% | 51.06% | 27.69% | 1.52% |
| Issuance of Common Stock | -- | -- | -100.00% | -96.61% | 3,630.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -68.02% | -8,017.39% | -115.03% | -97.38% | 6,235.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.91% | 45.35% | 222.75% | 83.71% | -747.76% |